Arsenic trioxide inhibits the growth of Calu-6 cells via inducing a G2 arrest of the cell cycle and apoptosis accompanied with the depletion of GSH

Cancer Letters

Volumn 270, Issue 1, 2008, Pages 40-55

  Han, Yong Hwan ^a   Kim, Sung Zoo ^a   Kim, Suhn Hee ^a   Park, Woo Hyun ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Apoptosis; Arsenic trioxide; Calu 6; Caspase; Cell cycle

Indexed keywords

ARSENIC TRIOXIDE; CASPASE INHIBITOR; CYCLIN DEPENDENT KINASE 1; GLUTATHIONE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; ARSENICALS; CASPASE 3; CELL LINE, TUMOR; G2 PHASE; GLUTATHIONE; HUMANS; LUNG NEOPLASMS; OXIDES; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 50949100342     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.041     Document Type: Article

References (54)

1. Soignet S.L., Maslak P., Wang Z.G., Jhanwar S., Calleja E., Dardashti L.J., Corso D., DeBlasio A., Gabrilove J., Scheinberg D.A., Pandolfi P.P., and Warrell Jr. R.P. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N. Engl. J. Med. 339 (1998) 1341-1348
2. Park W.H., Seol J.G., Kim E.S., Hyun J.M., Jung C.W., Lee C.C., Kim B.K., and Lee Y.Y. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res. 60 (2000) 3065-3071
3. Zhang W., Ohnishi K., Shigeno K., Fujisawa S., Naito K., Nakamura S., Takeshita K., Takeshita A., and Ohno R. The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 12 (1998) 1383-1391
4. Hyun Park W., Hee Cho Y., Won Jung C., Oh Park J., Kim K., Hyuck Im Y., Lee M.H., Ki Kang W., and Park K. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis. Biochem. Biophys. Res. Commun. 300 (2003) 230-235
5. Li J.J., Tang Q., Li Y., Hu B.R., Ming Z.Y., Fu Q., Qian J.Q., and Xiang J.Z. Role of oxidative stress in the apoptosis of hepatocellular carcinoma induced by combination of arsenic trioxide and ascorbic acid. Acta Pharmacol. Sin. 27 (2006) 1078-1084
6. Miller Jr. W.H., Schipper H.M., Lee J.S., Singer J., and Waxman S. Mechanisms of action of arsenic trioxide. Cancer Res. 62 (2002) 3893-3903
7. Seol J.G., Park W.H., Kim E.S., Jung C.W., Hyun J.M., Kim B.K., and Lee Y.Y. Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1. Biochem. Biophys. Res. Commun. 265 (1999) 400-404
8. Uslu R., Sanli U.A., Sezgin C., Karabulut B., Terzioglu E., Omay S.B., and Goker E. Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines. Clin. Cancer Res. 6 (2000) 4957-4964
9. Oketani M., Kohara K., Tuvdendorj D., Ishitsuka K., Komorizono Y., Ishibashi K., and Arima T. Inhibition by arsenic trioxide of human hepatoma cell growth. Cancer Lett. 183 (2002) 147-153
10. Pu Y.S., Hour T.C., Chen J., Huang C.Y., Guan J.Y., and Lu S.H. Cytotoxicity of arsenic trioxide to transitional carcinoma cells. Urology 60 (2002) 346-350
11. Nakagawa Y., Akao Y., Morikawa H., Hirata I., Katsu K., Naoe T., Ohishi N., and Yagi K. Arsenic trioxide-induced apoptosis through oxidative stress in cells of colon cancer cell lines. Life Sci. 70 (2002) 2253-2269
12. Li M., Cai J.F., and Chiu J.F. Arsenic induces oxidative stress and activates stress gene expressions in cultured lung epithelial cells. J. Cell. Biochem. 87 (2002) 29-38
13. Baj G., Arnulfo A., Deaglio S., Mallone R., Vigone A., De Cesaris M.G., Surico N., Malavasi F., and Ferrero E. Arsenic trioxide and breast cancer: analysis of the apoptotic, differentiative and immunomodulatory effects. Breast Cancer Res. Treat. 73 (2002) 61-73
14. Woo S.H., Park I.C., Park M.J., Lee H.C., Lee S.J., Chun Y.J., Lee S.H., Hong S.I., and Rhee C.H. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Int. J. Oncol. 21 (2002) 57-63
15. Zhang T.C., Cao E.H., Li J.F., Ma W., and Qin J.F. Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide. Eur. J. Cancer 35 (1999) 1258-1263
16. Baran C.P., Zeigler M.M., Tridandapani S., and Marsh C.B. The role of ROS and RNS in regulating life and death of blood monocytes. Curr. Pharm. Des. 10 (2004) 855-866
17. Dasmahapatra G., Rahmani M., Dent P., and Grant S. The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanism. Blood 107 (2006) 232-240
18. Simon H.U., Haj-Yehia A., and Levi-Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5 (2000) 415-418
19. Poot M., Teubert H., Rabinovitch P.S., and Kavanagh T.J. De novo synthesis of glutathione is required for both entry into and progression through the cell cycle. J. Cell. Physiol. 163 (1995) 555-560
20. Schnelldorfer T., Gansauge S., Gansauge F., Schlosser S., Beger H.G., and Nussler A.K. Glutathione depletion causes cell growth inhibition and enhanced apoptosis in pancreatic cancer cells. Cancer 89 (2000) 1440-1447
21. Lauterburg B.H. Analgesics and glutathione. Am. J. Ther. 9 (2002) 225-233
22. Wu X.X., Ogawa O., and Kakehi Y. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by l-buthionine sulfoximine. Int. J. Oncol. 24 (2004) 1489-1497
23. Dai J., Weinberg R.S., Waxman S., and Jing Y. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Blood 93 (1999) 268-277
24. Kito M., Akao Y., Ohishi N., Yagi K., and Nozawa Y. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Biochem. Biophys. Res. Commun. 291 (2002) 861-867
25. Maeda H., Hori S., Ohizumi H., Segawa T., Kakehi Y., Ogawa O., and Kakizuka A. Effective treatment of advanced solid tumors by the combination of arsenic trioxide and l-buthionine-sulfoximine. Cell Death Differ. 11 (2004) 737-746
26. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
27. Massague J. G1 cell-cycle control and cancer. Nature 432 (2004) 298-306
28. Coqueret O. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment?. Trends Cell Biol. 13 (2003) 65-70
29. Stark G.R., and Taylor W.R. Control of the G2/M transition. Mol. Biotechnol. 32 (2006) 227-248
30. Tsai L.H., Harlow E., and Meyerson M. Isolation of the human cdk2 gene that encodes the cyclin A- and adenovirus E1A-associated p33 kinase. Nature 353 (1991) 174-177
31. Shackelford R.E., Kaufmann W.K., and Paules R.S. Oxidative stress and cell cycle checkpoint function. Free Radic. Biol. Med. 28 (2000) 1387-1404
32. Boonstra J., and Post J.A. Molecular events associated with reactive oxygen species and cell cycle progression in mammalian cells. Gene 337 (2004) 1-13
33. Petty R.D., Nicolson M.C., Kerr K.M., Collie-Duguid E., and Murray G.I. Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application. Clin. Cancer Res. 10 (2004) 3237-3248
34. Han Y.W., Kim S.Z., Kim S.H., and Park W.H. The changes of intracellular H(2)O(2) are an important factor maintaining mitochondria membrane potential of antimycin A-treated As4.1 juxtaglomerular cells. Biochem. Pharmacol. 73 (2007) 863-872
35. Han Y.H., Kim S.H., Kim S.Z., and Park W.H. Intracellular GSH levels rather than ROS levels are tightly related to AMA-induced HeLa cell death. Chem. Biol. Interact. 171 (2008) 67-78
36. Porter A.G., and Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6 (1999) 99-104
37. Lazebnik Y.A., Kaufmann S.H., Desnoyers S., Poirier G.G., and Earnshaw W.C. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371 (1994) 346-347
38. Shao W., Fanelli M., Ferrara F.F., Riccioni R., Rosenauer A., Davison K., Lamph W.W., Waxman S., Pelicci P.G., Lo Coco F., Avvisati G., Testa U., Peschle C., Gambacorti-Passerini C., Nervi C., and Miller Jr. W.H. Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J. Natl. Cancer Inst. 90 (1998) 124-133
39. Ling Y.H., Jiang J.D., Holland J.F., and Perez-Soler R. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol. Pharmacol. 62 (2002) 529-538
40. Caamano J., Ruggeri B., Momiki S., Sickler A., Zhang S.Y., and Klein-Szanto A.J. Detection of p53 in primary lung tumors and nonsmall cell lung carcinoma cell lines. Am. J. Pathol. 139 (1991) 839-845
41. Liu Q., Hilsenbeck S., and Gazitt Y. Arsenic trioxide-induced apoptosis in myeloma cells: p53-dependent G1 or G2/M cell cycle arrest, activation of caspase-8 or caspase-9, and synergy with APO2/TRAIL. Blood 101 (2003) 4078-4087
42. Han Y.H., Kim S.Z., Kim S.H., and Park W.H. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis. Am. J. Physiol. Renal Physiol. 293 (2007) F511-F520
43. Yang J., Liu X., Bhalla K., Kim C.N., Ibrado A.M., Cai J., Peng T.I., Jones D.P., and Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275 (1997) 1129-1132
44. Cohen G.M. Caspases: the executioners of apoptosis. Biochem. J. 326 Pt. 1 (1997) 1-16
45. Kitamura K., Minami Y., Yamamoto K., Akao Y., Kiyoi H., Saito H., and Naoe T. Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis. Leukemia 14 (2000) 1743-1750
46. Szegezdi E., Cahill S., Meyer M., O'Dwyer M., and Samali A. TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt. Br. J. Cancer 94 (2006) 398-406
47. Felley-Bosco E., Weston A., Cawley H.M., Bennett W.P., and Harris C.C. Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am. J. Hum. Genet. 53 (1993) 752-759
48. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
49. Chou W.C., Jie C., Kenedy A.A., Jones R.J., Trush M.A., and Dang C.V. Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc. Natl. Acad. Sci. USA 101 (2004) 4578-4583
50. Kang Y.H., Yi M.J., Kim M.J., Park M.T., Bae S., Kang C.M., Cho C.K., Park I.C., Park M.J., Rhee C.H., Hong S.I., Chung H.Y., Lee Y.S., and Lee S.J. Caspase-independent cell death by arsenic trioxide in human cervical cancer cells: reactive oxygen species-mediated poly(ADP-ribose) polymerase-1 activation signals apoptosis-inducing factor release from mitochondria. Cancer Res. 64 (2004) 8960-8967
51. Jing Y., Dai J., Chalmers-Redman R.M., Tatton W.G., and Waxman S. Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway. Blood 94 (1999) 2102-2111
52. 3)-induced apoptosis in human glioblastoma cells. Cancer Sci. 96 (2005) 825-833
53. 3. Int. J. Mol. Med. 11 (2003) 479-484
54. Han S.S., Kim K., Hahm E.R., Park C.H., Kimler B.F., Lee S.J., Lee S.H., Kim W.S., Jung C.W., Park K., Kim J., Yoon S.S., Lee J.H., and Park S. Arsenic trioxide represses constitutive activation of NF-kappaB and COX-2 expression in human acute myeloid leukemia, HL-60. J. Cell. Biochem. 94 (2005) 695-707